Your browser doesn't support javascript.
loading
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
Willekens, Christophe; Laplane, Lucie; Dagher, Tracy; Benlabiod, Camelia; Papadopoulos, Nicolas; Lacout, Catherine; Rameau, Philippe; Catelain, Cyril; Alfaro, Alexia; Edmond, Valérie; Signolle, Nicolas; Marchand, Valentine; Droin, Nathalie; Hoogenboezem, Remco; Schneider, Rebekka K; Penson, Alex; Abdel-Wahab, Omar; Giraudier, Stephane; Pasquier, Florence; Marty, Caroline; Plo, Isabelle; Villeval, Jean-Luc; Constantinescu, Stefan N; Porteu, Françoise; Vainchenker, William; Solary, Eric.
Afiliação
  • Willekens C; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Laplane L; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Dagher T; Département d'hématologie, Gustave Roussy Cancer Campus, Villejuif, France.
  • Benlabiod C; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Papadopoulos N; Institut d'Histoire et Philosophie des Sciences et des Techniques, Université Paris I Panthéon-Sorbonne, Paris, France.
  • Lacout C; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Rameau P; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Catelain C; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Alfaro A; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Edmond V; Institut d'Histoire et Philosophie des Sciences et des Techniques, Université Paris I Panthéon-Sorbonne, Paris, France.
  • Signolle N; Ludwig Institute for Cancer Research Brussels, Brussels, Belgium.
  • Marchand V; Université catholique de Louvain and de Duve Institute, Brussels, Belgium.
  • Droin N; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Hoogenboezem R; Gustave Roussy Cancer Campus, Villejuif, France.
  • Schneider RK; Gustave Roussy Cancer Campus, Villejuif, France.
  • Penson A; Gustave Roussy Cancer Campus, Villejuif, France.
  • Abdel-Wahab O; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Giraudier S; Gustave Roussy Cancer Campus, Villejuif, France.
  • Pasquier F; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Marty C; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Plo I; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Villeval JL; Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Constantinescu SN; Gustave Roussy Cancer Campus, Villejuif, France.
  • Porteu F; Department of Hematology, Erasmus University, Rotterdam, The Netherlands.
  • Vainchenker W; Department of Hematology, Erasmus University, Rotterdam, The Netherlands.
  • Solary E; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany.
Leukemia ; 37(6): 1287-1297, 2023 06.
Article em En | MEDLINE | ID: mdl-37100881

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
...